Reports
Reports
Sale
The global microbial fermentation technology market size was valued at USD 30.7 billion in 2023, driven by the increasing demand for bio-based products across the globe. The market size is anticipated to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to achieve a value of USD 49.8 billion by 2032.
Microbial fermentation is the biochemical process of extracting chemical energy from carbohydrates without oxygen. The process occurs in bacteria, yeasts, or even in muscles of humans. Microbial fermentation is performed by metabolic enzymes. A wide range of microorganisms are present during the fermentation and each of the microorganisms has a particular set of enzymes which is responsible for the amalgamation of sophisticated mixtures byproduct, which develops the foul taste and smell of fermented foods. The most common example of fermented edibles is alcohol beverages such as wine and beer, among others. The existence of microbial fermentation is spotted in almost every biomass.
The definition of microbial fermentation is anaerobic conversion of sugar into alcohol and yeast. However, in the pharmaceutical sector, it is widely used to manage microorganisms for antibiotics, therapeutic proteins, enzymes, and insulin. Temperature-controlled tanks, also known as fermenters, are widely used for the fermentation with correct concentration of nutrients to harvest the solicited organism.
The growth of the market is driven by several factors such as the increasing popularity of continuous fermentation processes due to their potential for increased productivity and reduced production costs compared to traditional batch fermentation. Continuous systems can provide a more stable environment for microorganisms, leading to higher yields and faster product generation. Rising automation and robotics developments have made it possible for researchers to screen a variety of microbes and fermentation conditions at high throughput, further propelling the global microbial fermentation technology market growth.
Additionally, the research of microbial fermentation is increasingly using omics technologies, such as genomes, transcriptomics, proteomics, and metabolomics, among others. These technologies offer a thorough understanding of the genetic and metabolic characteristics of microorganisms, assisting in strain selection and procedure optimization.
Microbial fermentation is increasingly being explored as a means of converting waste materials into valuable products. This aligns with the principles of the circular economy, where waste is seen as a resource, promoting sustainable and environmentally friendly production methods. The rising emphasis on the use of renewable resources, such as feedstocks for microbial fermentation, is also increasing the microbial fermentation technology market demand. Agricultural byproducts, lignocellulosic biomass, and other non-food sources are some of them, reducing the dependency on fossil fuels and conventional raw materials.
Market Breakup by Product Type
Market Breakup by End User
Market Breakup by Region
The market for microbial fermentation has been witnessing significant growth during the historical period and is expected to keep growing in the coming years as well. The increasing demand for fermented food products and beverages, including natural and organic food products, is driving the market growth. Rising consumer health consciousness is increasingly contributing to the market growth. The ability of microbial fermentation to keep the food products intact and safe to eat for a longer time span is directly contributing to the global microbial fermentation market share. The increasing prevalence of infectious diseases is propelling the demand for more fermented microbial products, such as vaccines and antibiotics, which are used to treat patients from infections.
The increasing demand for bio-based products is also supporting the market growth as microbial fermentation can be used to enhance the production of bio-based chemicals, fields, and other materials, which ultimately results in the fulfillment of eco-conscious consumers and industries. Microbial fermentation is widely used in the food and beverage industry to produce various products, including yogurt, cheese, bread, beer, wine, and other fermented foods. The growing demand for these products is augmenting the demand for microbial fermentation on a larger scale in the market.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Microbial Fermentation Technology Market Overview
3.1 Global Microbial Fermentation Technology Market Historical Value (2017-2023)
3.2 Global Microbial Fermentation Technology Market Forecast Value (2024-2032)
4 Global Microbial Fermentation Technology Market Landscape
4.1 Global Microbial Fermentation Technology Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Microbial Fermentation Technology Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Microbial Fermentation Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Microbial Fermentation Technology Market Segmentation
6.1 Global Microbial Fermentation Technology Market by Product Type
6.1.1 Market Overview
6.1.2 Medical Products
6.1.2.1 Antibiotics
6.1.2.2 Probiotics
6.1.2.3 Monoclonal Antibodies
6.1.2.4 Recombinant Proteins
6.1.2.5 Others
6.1.3 Industrial Products
6.1.4 Alcohol Beverages
6.1.5 Food and Feed Products
6.1.6 Others
6.2 Global Microbial Fermentation Technology Market by End User
6.2.1 Market Overview
6.2.2 Bio-Pharmaceutical Companies
6.2.3 Contract Research Organizations
6.2.4 CMOs and CDMOs
6.2.5 Academics and Research Institutes
6.2.6 Food and Feed Institutes
6.2.7 Others
6.3 Global Microbial Fermentation Technology Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Microbial Fermentation Technology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Microbial Fermentation Technology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Microbial Fermentation Technology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Microbial Fermentation Technology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Microbial Fermentation Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Biocon Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Bio Vectra Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Danone Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 F. Hoffmann-La Roche AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Koninklijke DSM NV
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Lonza
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Novozymes A/S
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 TerraVia Holdings, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Biozeen
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 United Breweries Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Microbial Fermentation Technology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 30.7 billion in 2023, driven by the increasing demand for bio-based products.
The market is anticipated to grow at a CAGR of 5.5% during the forecast period of 2024-2032, and likely to reach a market value of USD 49.8 billion by 2032.
The increasing prevalence of infectious diseases and rising demand for natural and organic food products globally are among the factors aiding the market growth.
The research of microbial fermentation is increasingly using omics technologies such as genomes, transcriptomics, proteomics, and metabolomics due to the detailed understanding they provide which further helps in strain selection and progression of the procedure.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different type of products in the market are medical products, industrial products, alcohol beverages, food and feed products, among others.
End users in the market are bio-pharmaceutical companies, contract research organizations, CMOs & CDMOs, academics and research institutes, food and feed institutes, among others.
Key players involved in the market are Biocon Ltd., Bio Vectra Inc., Danone Ltd., F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza, Novozymes A/S, TerraVia Holdings, Inc., United Breweries Ltd., and Biozeen.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.